Steffi Lehmann

Countries

This corpus build does not record which country the citing authors are in, so the country breakdown is not computed. The other breakdowns below are unaffected.

Institutions

• Roche (Switzerland)47.7%
• Inserm8.1%
• Roche Pharma AG (Germany)6.5%
• Radboud University Nijmegen5.4%
• Radboud University Medical Center4.4%
• Chinese Academy of Medical Sciences & Peking Union Medical College3.9%
• Other24.1%

Fields

• Medicine56.3%
• Biochemistry, Genetics and Molecular Biology29.3%
• Engineering6.6%
• Immunology and Microbiology5.5%
• Materials Science0.7%
• Nursing0.7%
• Other0.9%

Topics

• CAR-T cell therapy research16.8%
• Monoclonal and Polyclonal Antibodies Research15.4%
• Cancer Cells and Metastasis11.8%
• 3D Printing in Biomedical Research7.4%
• Immunotherapy and Immune Responses7.1%
• Cancer, Hypoxia, and Metabolism6.4%
• Other35%